1. Home
  2. ALGT vs MESO Comparison

ALGT vs MESO Comparison

Compare ALGT & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegiant Travel Company

ALGT

Allegiant Travel Company

HOLD

Current Price

$74.64

Market Cap

2.1B

ML Signal

HOLD

Logo Mesoblast Limited

MESO

Mesoblast Limited

N/A

Current Price

$14.79

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALGT
MESO
Founded
1997
2004
Country
United States
Australia
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
ALGT
MESO
Price
$74.64
$14.79
Analyst Decision
Buy
Buy
Analyst Count
14
3
Target Price
★ $117.43
$37.00
AVG Volume (30 Days)
★ 410.4K
269.1K
Earning Date
11-04-2026
08-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.62
N/A
EPS
★ 1.80
N/A
Revenue
★ $2,606,579,000.00
N/A
Revenue This Year
$42.77
$51.63
Revenue Next Year
$22.28
$63.39
P/E Ratio
$41.40
★ N/A
Revenue Growth
★ 3.74
N/A
52 Week Low
$61.36
$11.89
52 Week High
$123.63
$21.50

Technical Indicators

Market Signals
Indicator
ALGT
MESO
Relative Strength Index (RSI) 54.79 57.35
Support Level $72.89 $13.77
Resistance Level $85.94 $16.06
Average True Range (ATR) 3.84 0.47
MACD 1.04 0.34
Stochastic Oscillator 80.25 82.19

Price Performance

Historical Comparison
ALGT
MESO

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

Share on Social Networks: